🏥
🏥 Health
US drug agency approves daraxonrasib — a breakthrough treatment for pancreatic cancer
The US Food and Drug Administration has approved daraxonrasib, a new treatment for pancreatic cancer — one of the world's deadliest tumours. Experts have hailed the drug as a game changer in oncology. The approval marks a significant milestone for patients with this particularly difficult-to-treat cancer.
Similar stories
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!